Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 1-year International Multicenter Retrospective Cohort Study
J Am Acad Dermatol. 2024 Apr 25:S0190-9622(24)00654-6.
doi: 10.1016/j.jaad.2024.03.048.
Online ahead of print.
1 Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
2 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
3 Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
4 Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
5 Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
6 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
7 Department of Dermatology, Centro Hospitalar de Santo António, 4099-001 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal.
8 Department of Dermatology, Centro Hospitalar de Santo António, 4099-001 Porto, Portugal.
9 Dermatrials Research Inc. and Venderm Consulting, Hamilton, Ontario, Canada.
10 Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Section of Community Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
11 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Toronto, Ontario, Canada. Electronic address: jensen.yeung@utoronto.ca.